TriReme Medical Lines Up Asian Strategy With Key Appointment of New Board Members

Avantium announces the successful start-up of its polyester pilot plant at the Chemelot
site in Geleen, the Netherlands. The polyester plant is the first part of the pilot plant that
Avantium is building at its new site to demonstrate its YXY technology for green
materials and fuels. Avantium’s monomer pilot plant is scheduled to become operational
in the second half of 2011.

TriReme Medical Lines Up Asian Strategy With Key Appointment of New Board Members Read More »

Avantium Announces Start Up of YXY-Polyester Pilot Plant

Avantium announces the successful start-up of its polyester pilot plant at the Chemelot
site in Geleen, the Netherlands. The polyester plant is the first part of the pilot plant that
Avantium is building at its new site to demonstrate its YXY technology for green
materials and fuels. Avantium’s monomer pilot plant is scheduled to become operational
in the second half of 2011.

Avantium Announces Start Up of YXY-Polyester Pilot Plant Read More »

Smaato Raises $7M Venture Capital Round for International Expansion of Mobile Advertising Platform

Redwood Shores, CA / Singapore / Hamburg (www.smaato.com): January
26, 2011: Smaato (www.smaato.com), the leading mobile ad optimizer and mobile
advertising company, today announced the closing of a new institutional round of
funding. Singapore’s EDBI led the $7 million round, with participation from existing
shareholders including global private equity firm aeris CAPITAL. The new funds will
help fuel Smaato’s international expansion, in particular to extend its presence in
Asia from its Asian headquarters in Singapore.

Smaato Raises $7M Venture Capital Round for International Expansion of Mobile Advertising Platform Read More »

Inviragen and Duke-NUS Form Collaborative Vaccine Research and Development Program

Inviragen and Duke-NUS Form Collaborative Vaccine Research and Development
Program Fort Collins, CO and Singapore – January 26, 2011 – Inviragen, Inc. and the DukeNational University of Singapore Graduate Medical School (“Duke-NUS”) announced today that
they have completed a memorandum of understanding (MOU) to establish a partnership
between the two organizations

Inviragen and Duke-NUS Form Collaborative Vaccine Research and Development Program Read More »